bladder cancer
Conditions
Interventions
Case series:None
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. TURB/re-TURB postoperative pathology identified NMIBC; 2. aged 18~80 years old; 3. ECOG score 0-1; 4. Received postoperative BCG bladder perfusion treatment; 5. Informed consent was signed by individual patients; 6. Enrolled patients agreed to refuse other bladder cancer treatment.
Exclusion criteria
Exclusion criteria: 1. TURB/re-TURB postoperative pathological confirmation of MIBC; 2. Other malignant tumor disease history; 3. Acute infection of various pathogens or chronic inflammatory diseases; 4. Congenital or acquired immunodeficiency; 5. Severe systemic or chronic expendable diseases (diabetes, cardiovascular disease and liver and kidney dysfunction); 6. Blood system diseases or taking drugs affecting hematopoietic function; 7. Chemoradiotherapy or biotherapy history; 8. Involved in other clinical trials; 9. Other circumstances considered unsuitable by researchers (e.g. mental disorders).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exon mutation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory indicators; | — |
Countries
China
Contacts
Public ContactYi-Ping Zhu
Fudan University Shanghai Cancer Center
Outcome results
None listed